—

Illumina Inc (ILMN) — Technical state

As of 2026-11-16 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 56 out of 100 (momentum 75 · quality 78 · valuation 25), as of 2026-11-18.
  • Signal: Down 4.4% at the close — Already below its 50-day; one of the day's sharpest drops. (as of 2026-11-16)
  • Trend: Illumina Inc trades 20.4% below its 50-day and 10.1% above its 200-day moving average. (as of 2026-11-16)
  • Index seat: HALO Growth 100

Illumina builds the sequencing and array instruments, and the reagents and flow cells that run through them, used to read DNA and RNA. It sells whole-genome, exome and targeted sequencing kits and services to research centres, hospitals, government labs and biotech and diagnostics companies, mostly through direct sales and distributors.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ILMN overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Down 4.4% at the close

Already below its 50-day; one of the day's sharpest drops.

Ranked #34 on today’s Directional Flow — Top scores list (scan of 2026-11-17).

The moving-average stack

FAQ · from the current data · as of 2026-11-16

Quick answers

What is the current Closelooknet signal on ILMN?

Down 4.4% at the close — Already below its 50-day; one of the day's sharpest drops. As of 2026-11-16; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ILMN above its 50-day and 200-day moving averages?

As of 2026-11-16, Illumina Inc trades -20.4% below its 50-day and +10.1% above its 200-day average, with the 20-day -18% away.

How far is ILMN from its 52-week high?

36% below the 52-week high and 125% above the 52-week low, as of 2026-11-16.

Mentioned on Closelooknet

Where ILMN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

same Closelooknet index seat first, then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.